Grifols (GIFLF) Total Debt (2009 - 2025)
Grifols' (GIFLF) quarterly Total Debt came in at $10.6 billion in Q4 2025, down 2.6% on a YoY basis from $10.9 billion in Q4 2024, and down 2.6% quarter-over-quarter from $10.9 billion in Q4 2024.
Analysis
Grifols (GIFLF) Total Debt (2009 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Total Debt for 17 consecutive years, with $10.6 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Total Debt fell 2.6% year-over-year to $10.6 billion; the trailing twelve-month figure through Dec 2025 stood at $10.6 billion (down 2.6% YoY), and the FY2025 full-year result was $10.3 billion, down 5.46% from the prior year.
- Total Debt eased to $10.6 billion in Q4 2025 per GIFLF's latest filing, from $10.9 billion in the prior quarter.
- Across five years, Total Debt topped out at $11.9 billion in Q4 2023 and bottomed at $10.6 billion in Q4 2025.
- Historically, Total Debt has averaged $11.2 billion across 5 years, with a median of $11.1 billion in 2022.
- The sharpest annual moves came in 2021 and 2024: Total Debt surged 39.38% in 2021, then dropped 8.68% in 2024.
- Over 5 years, Total Debt stood at $11.7 billion in 2021, then declined by 5.03% to $11.1 billion in 2022, then grew by 7.28% to $11.9 billion in 2023, then slipped by 8.68% to $10.9 billion in 2024, then declined by 2.6% to $10.6 billion in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $10.6 billion, $10.9 billion, and $11.9 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 10.58 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.58 Bn |
| Dec 31, 2024 | 10.86 Bn |
| Dec 31, 2023 | 11.90 Bn |
| Dec 31, 2022 | 11.09 Bn |
| Dec 31, 2021 | 11.68 Bn |
| Dec 31, 2020 | 8.38 Bn |
| Sep 30, 2020 | 8.23 Bn |
| Mar 31, 2020 | 7.94 Bn |
| Dec 31, 2019 | 7.98 Bn |
| Sep 30, 2019 | 8.14 Bn |
| Dec 31, 2018 | 7.28 Bn |
| Sep 30, 2018 | 7.40 Bn |
| Jun 30, 2018 | 7.43 Bn |
| Mar 31, 2018 | 8.84 Bn |
| Dec 31, 2017 | 7.13 Bn |
| Jun 30, 2017 | 6.81 Bn |
| Dec 31, 2016 | 5.34 Bn |
| Sep 30, 2016 | 5.26 Bn |
| Jun 30, 2016 | 5.34 Bn |
| Mar 31, 2016 | 4.88 Bn |